Nitzan Rosenfeld

Granta Park
Cambridge, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 70 publications

Outcomes from the NHS-Galleri trial: the good, the bad, and the uncertain.

Outcomes from the NHS-Galleri trial: the good, the bad, and the uncertain.

Journal: BJC reports

Published: August 04, 2026

A scalable deep-learning framework for cancer detection using cell-free DNA shallow whole-genome sequencing.

A scalable deep-learning framework for cancer detection using cell-free DNA shallow whole-genome sequencing.

Journal: Science advances

Published: July 10, 2026

Personalized ctDNA analysis for detection of residual disease and recurrence in surgically treated HNSCC patients.

Personalized ctDNA analysis for detection of residual disease and recurrence in surgically treated HNSCC patients.

Journal: NPJ precision oncology

Published: November 19, 2025

Cell-free DNA size deconvolution resolves nucleosomal origins and reveals tumor-associated fragmentomic alterations.

Cell-free DNA size deconvolution resolves nucleosomal origins and reveals tumor-associated fragmentomic alterations.

Journal: Nature communications

Published: September 22, 2025

ctDNA monitoring using tumor-informed copy number analysis.

ctDNA monitoring using tumor-informed copy number analysis.

Journal: EMBO molecular medicine

Published: August 05, 2025

Promises and pitfalls of multi-cancer early detection using liquid biopsy tests.

Promises and pitfalls of multi-cancer early detection using liquid biopsy tests.

Journal: Nature reviews. Clinical oncology

Published: May 15, 2025

A large-scale retrospective study in metastatic breast cancer patients using circulating tumour DNA and machine learning to predict treatment outcome and progression-free survival.

A large-scale retrospective study in metastatic breast cancer patients using circulating tumour DNA and machine learning to predict treatment outcome and progression-free survival.

Journal: Molecular oncology

Published: January 31, 2025

Second Primary Lung Cancer-Potential Areas of Ambiguity.

Second Primary Lung Cancer-Potential Areas of Ambiguity.

Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer

Published: September 15, 2024

Recurrence prediction using circulating tumor DNA in patients with early-stage non-small cell lung cancer after treatment with curative intent: A retrospective validation study.

Recurrence prediction using circulating tumor DNA in patients with early-stage non-small cell lung cancer after treatment with curative intent: A retrospective validation study.

Journal: PLoS medicine

Published: September 04, 2024

A standardized framework for robust fragmentomic feature extraction from cell-free DNA sequencing data.

A standardized framework for robust fragmentomic feature extraction from cell-free DNA sequencing data.

Journal: Genome biology

Published: September 03, 2024

LIBELULE: A Randomized Phase III Study to Evaluate the Clinical Relevance of Early Liquid Biopsy in Patients With Suspicious Metastatic Lung Cancer.

LIBELULE: A Randomized Phase III Study to Evaluate the Clinical Relevance of Early Liquid Biopsy in Patients With Suspicious Metastatic Lung Cancer.

Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer

Published: July 30, 2024

Second Primary Lung Cancer - An Emerging Issue in Lung Cancer Survivors.

Second Primary Lung Cancer - An Emerging Issue in Lung Cancer Survivors.

Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer

Published: March 07, 2024

Showing 1-12 of 70

Last Updated: 09/26/2026